Group Unnati

Bengaluru, India Founded: 2003 • Age: 23 yrs
Pharmaceutical distribution network serving ethical medicines across Indian regions.

About Group Unnati

Group Unnati is a Healthcare company based in Bengaluru (India) founded in 2003. Pharmaceutical distribution network serving ethical medicines across Indian regions. It operates on a B2B and D2C model. The company has 530 employees. Its website groupunnati.com draws about 63 thousand monthly visits. Its Indian entity Vardhman Medisales Private Limited reported revenue of β‚Ή901 Cr. Group Unnati offers products and services including Pharmaceutical Distribution and Medicine Supply Platform. Its focus areas include Pharmaceuticals, Distribution, Ethical Medicines and Pharma Tech. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.

Company details

Unnati Group is a leading pharmaceutical distribution entity in India, operating through subsidiaries like Vardhman Medisales, Focus Medisales, and Medihauxe Healthcare. They focus on supplying ethical medicines and pharma solutions using advanced technology and a vast network. Based primarily in Karnataka, with branches in cities like Bangalore, Belagavi, Mangalore, Shivamogga, and Mysuru, they prioritize customer satisfaction and reliable delivery, even during challenges like pandemics, to meet medicine needs for various clients including companies and individuals.

  • Headquarters Bengaluru, India
  • Employees 530
  • Sectors
    Healthcare
  • Website category Finance · Banking Credit and Lending
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website groupunnati.com
  • Legal Name Vardhman Medisales Pvt Ltd
  • Date of Incorporation 08 Apr, 2022
  • Jurisdiction Bengaluru, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹901 Cr

    FY 2025 · +38% YoY

  • Net Profit
    ₹14.33 Cr

    FY 2025 · 2% margin

  • EBITDA
    ₹30.55 Cr

    FY 2025 · 3% margin

  • Employee Count
    530

Products & Services of Group Unnati

Group Unnati offers a comprehensive portfolio of products and services, including Pharmaceutical Distribution and Medicine Supply Platform.

Pharmaceutical Distribution
Supply Services

Service for ethical medicine distribution and supply networks

Medicine Supply Platform
Logistics Platform

Platform delivering pharma solutions to customers in India

Board of directors of Vardhman Medisales Private Limited (Group Unnati)

Vardhman Medisales Private Limited is the primary company behind Group Unnati. The boards of the 4 registered companies of Group Unnati currently have 9 directors; the longest-serving is Usha Chowhan, appointed in 2004. 9 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Usha Chowhan
DIN 00393175
Director17 May 200422 yrs 5 moVardhman Pharma Distributors Private Limited, Vardhman Medisales Private Limited
Arvind Kumar Venkat
DIN 02304618
Nominee Director23 Oct 200818 yrsVardhman Pharma Distributors Private Limited, Vardhman Medisales Private Limited
Mahendra Bhoormal Chowhan
DIN 00092275
Director22 Jul 200917 yrs 3 moSrinivasa Medisales Private Limited, Vardhman Pharma Distributors Private Limited, Vardhman Medisales Private Limited
Premkumar Karra
DIN 00803203
Nominee Director26 Nov 200916 yrs 11 moVardhman Pharma Distributors Private Limited
Ankit Arvindkumar Jain
DIN 07244123
Director25 Sep 20179 yrs 1 moSrinivasa Medisales Private Limited
Sreenivasa Reddy
DIN 10217664
Director28 Jun 20233 yrs 4 moWohlstand Pharma Private Limited
Krishnamurihy Hanumanthrao Toppaladodi
DIN 10217663
Director28 Jun 20233 yrs 4 moWohlstand Pharma Private Limited
Andanayya Veerbhadrayya Saraganachari
DIN 10418153
Director07 Dec 20232 yrs 11 moWohlstand Pharma Private Limited
Gaurav Chaturvedi
DIN 06938743
Director09 Jan 20242 yrs 9 moVardhman Medisales Private Limited

Financials of Group Unnati

Figures of Vardhman Medisales Private Limited, the primary company behind Group Unnati, for FY 2025. Revenue was ₹901 Cr (+38% year on year). Net profit was ₹14.33 Cr (2% margin). EBITDA was ₹30.55 Cr (3% margin).

  • ₹901 CrRevenue · FY 2025 · +38% YoY
  • ₹14.33 CrNet profit · 2% margin
  • ₹30.55 CrEBITDA · 3% margin
  • ₹37.01 CrPaid-up capital
  • 530Employees (provident fund records)

Balance sheet, profit and loss, cash flow and ratios of Vardhman Medisales Private Limited are on its company page.

Premium access

Detailed financial statements for Group Unnati

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Group Unnati

Group Unnati has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
Premium access

Detailed similar companies of Group Unnati

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Group Unnati

The website of Group Unnati (groupunnati.com) receives about 63K visits a month and ranks #561,213 among all websites worldwide, #7,302 in Banking Credit and Lending.

  • Monthly visits
    63K

    ▼ 4.1% vs previous month

  • Unique visitors
    10.2K

    per month

  • Global rank
    #561,213

    among all websites

  • Category rank
    #7,302

    Finance · Banking Credit and Lending

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Group Unnati

Group Unnati was founded in 2003.

Group Unnati is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Group Unnati has 530 employees.

The primary company behind Group Unnati, Vardhman Medisales Private Limited, reported revenue of β‚Ή901 Cr for FY 2025, up 38% year on year.

Unnati Group is a leading pharmaceutical distribution entity in India, operating through subsidiaries like Vardhman Medisales, Focus Medisales, and Medihauxe Healthcare. They focus on supplying ethical medicines and pharma solutions using advanced technology and a vast network. Based primarily in Karnataka, with branches in cities like Bangalore, Belagavi, Mangalore, Shivamogga, and Mysuru, they prioritize customer satisfaction and reliable delivery, even during challenges like pandemics, to meet medicine needs for various clients including companies and individuals.

Group Unnati's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.

Group Unnati offers Pharmaceutical Distribution and Medicine Supply Platform.

Group Unnati is associated with 4 legal entities: Vardhman Medisales Private Limited, Srinivasa Medisales Private Limited, Wohlstand Pharma Private Limited and others.

The legal entities of Group Unnati currently have 10 directors, including Mahendra Bhoormal Chowhan, Ankit Arvindkumar Jain, Andanayya Veerbhadrayya Saraganachari and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available